Corcept Therapeutics Incorporated (%)
(CORT)
Years |
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec |
Annual |
2004 |
0 |
0 |
0 |
0 |
-4.6 |
-31.1 |
-18.4 |
31.8 |
-5.5 |
-12.2 |
-35.6 |
41.1 |
0 |
2005 |
-19.4 |
-9.1 |
-0.9 |
4.4 |
-16.9 |
46.2 |
6.8 |
-9.8 |
-9.9 |
-2.6 |
-6.6 |
-19.8 |
-41.6 |
2006 |
34.5 |
-1.2 |
7.8 |
-3.3 |
-5.7 |
-15.1 |
-7.7 |
-67.7 |
-23.1 |
-14 |
10 |
39.8 |
-66.3 |
2007 |
-0.8 |
-9.8 |
-18.2 |
72.2 |
-10.3 |
97.1 |
-17.9 |
42.7 |
52.7 |
-25.9 |
-18.7 |
4.8 |
151.2 |
2008 |
-14.9 |
-2.3 |
25.3 |
-13.4 |
-16.1 |
-16.2 |
-5.1 |
0 |
-30.7 |
2.3 |
-22.7 |
0 |
-67 |
2009 |
-21.6 |
42.5 |
4.4 |
-25.2 |
-1.1 |
-8 |
39.5 |
-2.7 |
36.4 |
34.7 |
10.9 |
24.1 |
172.6 |
2010 |
-7.9 |
9.4 |
1.8 |
18.6 |
-4.4 |
-3.4 |
4.2 |
-14.2 |
39.4 |
-8.2 |
9.2 |
-1 |
38.9 |
2011 |
4.9 |
-7.7 |
13.6 |
3.5 |
12.3 |
-19.2 |
-10.3 |
-21 |
9.5 |
2.3 |
-0.3 |
8.2 |
-11.4 |
2012 |
0.3 |
14.6 |
0 |
-4.8 |
9.4 |
9.8 |
-19.4 |
-20.2 |
-3.5 |
-10.4 |
-42.4 |
-0.7 |
-58.2 |
2013 |
51.8 |
-24.4 |
22 |
-11.5 |
2.8 |
-5 |
22 |
-21.3 |
-4.2 |
6.3 |
27.2 |
49.3 |
124.5 |
2014 |
7.2 |
-4.7 |
32.9 |
1.4 |
-48.9 |
23.9 |
-14.6 |
15.5 |
-2.9 |
21.3 |
-6.8 |
-1 |
-6.5 |
2015 |
-3 |
13.8 |
69.2 |
3 |
6.1 |
-1.8 |
-16.1 |
-0.8 |
-24.8 |
-1.9 |
43.1 |
-5.7 |
66 |
2016 |
-26.7 |
4.7 |
22.5 |
1.9 |
24.7 |
-8.2 |
6.2 |
-8.1 |
22 |
6.8 |
20.9 |
-13.5 |
45.8 |
2017 |
-2.1 |
26.4 |
21.9 |
-13 |
18.6 |
4.3 |
5.7 |
33.7 |
15.8 |
2 |
-8.9 |
0.7 |
148.8 |
2018 |
27.5 |
-34 |
8.3 |
1.4 |
10.9 |
-15 |
-16.5 |
14.4 |
-6.7 |
-16.2 |
18.6 |
-4.1 |
-26 |
2019 |
-16.3 |
11.5 |
-5.9 |
5.3 |
-20.6 |
13.3 |
4 |
6.8 |
15.5 |
-0.5 |
-8.3 |
-6.6 |
-8.8 |
2020 |
3.6 |
-0.3 |
-5.5 |
6.5 |
19.6 |
11.1 |
-11.1 |
-15.1 |
37.1 |
-3.6 |
34.9 |
15.6 |
114.8 |
2021 |
8 |
-10.5 |
-5.9 |
-4.2 |
-4.7 |
1.2 |
-5.6 |
2.5 |
-7.5 |
-8.5 |
16.7 |
-10 |
-23.1 |
2022 |
-6.7 |
|
|
|
|
|
|
|
|
|
|
|
-5.9 |